For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow gems #146
Wednesday 28 April 2021, 12:32 AM

“Tiny habits: a new way to change behaviour”
Director of the Behavior Design Lab at Stanford University BJ Fogg says that you cannot rely on motivation to develop good habits.1 They have to be nu
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
https://bit.ly/3fTE2gC (RNZ, 3.10pm, 10 February 2021)